Cutera (CUTR) Competitors $0.04 -0.07 (-63.86%) Closing price 03/12/2025Extended Trading$0.04 0.00 (0.00%) As of 03/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CUTR vs. HSCS, BBLG, TTOO, BJDX, NDRA, TIVC, VERO, STSS, AVGR, and QNRXShould you be buying Cutera stock or one of its competitors? The main competitors of Cutera include Heart Test Laboratories (HSCS), Bone Biologics (BBLG), T2 Biosystems (TTOO), Bluejay Diagnostics (BJDX), ENDRA Life Sciences (NDRA), Tivic Health Systems (TIVC), Venus Concept (VERO), Sharps Technology (STSS), Avinger (AVGR), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry. Cutera vs. Heart Test Laboratories Bone Biologics T2 Biosystems Bluejay Diagnostics ENDRA Life Sciences Tivic Health Systems Venus Concept Sharps Technology Avinger Quoin Pharmaceuticals Heart Test Laboratories (NASDAQ:HSCS) and Cutera (NASDAQ:CUTR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, community ranking, profitability, risk, media sentiment, earnings and valuation. Does the MarketBeat Community prefer HSCS or CUTR? Cutera received 330 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 85.71% of users gave Heart Test Laboratories an outperform vote while only 62.69% of users gave Cutera an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes685.71% Underperform Votes114.29%CuteraOutperform Votes33662.69% Underperform Votes20037.31% Do analysts prefer HSCS or CUTR? Heart Test Laboratories presently has a consensus price target of $13.00, indicating a potential upside of 357.75%. Cutera has a consensus price target of $3.00, indicating a potential upside of 7,592.31%. Given Cutera's higher probable upside, analysts clearly believe Cutera is more favorable than Heart Test Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Cutera 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to HSCS or CUTR? In the previous week, Heart Test Laboratories had 3 more articles in the media than Cutera. MarketBeat recorded 4 mentions for Heart Test Laboratories and 1 mentions for Cutera. Heart Test Laboratories' average media sentiment score of 0.81 beat Cutera's score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heart Test Laboratories 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cutera 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of HSCS or CUTR? 17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 90.7% of Cutera shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Comparatively, 0.4% of Cutera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, HSCS or CUTR? Heart Test Laboratories has a beta of 2.77, meaning that its stock price is 177% more volatile than the S&P 500. Comparatively, Cutera has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Which has better earnings & valuation, HSCS or CUTR? Heart Test Laboratories has higher earnings, but lower revenue than Cutera. Heart Test Laboratories is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K208.85-$6.61M-$7.48-0.38Cutera$155.21M0.01-$162.83M-$6.58-0.01 Is HSCS or CUTR more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Cutera's net margin of -84.86%. Cutera's return on equity of 0.00% beat Heart Test Laboratories' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -117.76% -84.09% Cutera -84.86%N/A -45.07% SummaryHeart Test Laboratories beats Cutera on 10 of the 18 factors compared between the two stocks. Remove Ads Get Cutera News Delivered to You Automatically Sign up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CUTR vs. The Competition Export to ExcelMetricCuteraElectromedical equipment IndustryComputer SectorNASDAQ ExchangeMarket Cap$787,000.00$3.25B$23.52B$8.06BDividend YieldN/A1.62%2.83%4.01%P/E Ratio-0.0114.8942.8319.03Price / Sales0.0142.731,979.1993.17Price / CashN/A44.0934.6134.64Price / Book0.003.456.234.33Net Income-$162.83M$89.74M$735.89M$247.06M7 Day PerformanceN/A-1.19%-0.13%-0.37%1 Month PerformanceN/A-10.48%49,592.39%-3.85%1 Year PerformanceN/A-19.34%52,115.24%1.27% Cutera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CUTRCutera1.9983 of 5 stars$0.04-63.9%$3.00+7,592.3%-97.2%$787,000.00$155.21M-0.01460Analyst ForecastGap DownHigh Trading VolumeHSCSHeart Test Laboratories2.9886 of 5 stars$3.05+3.7%$13.50+342.6%-75.7%$2.99M$14,700.00-0.3910BBLGBone Biologics1.2244 of 5 stars$0.83+0.3%N/A-58.7%$2.72MN/A0.002Short Interest ↓Gap UpTTOOT2 BiosystemsN/A$0.13+0.1%$5.00+3,896.8%-96.1%$2.63M$7.68M0.00180Analyst ForecastGap UpBJDXBluejay Diagnostics1.1521 of 5 stars$4.07+0.7%N/A-98.8%$2.25M$250,000.000.009Short Interest ↓Gap UpNDRAENDRA Life Sciences2.0094 of 5 stars$4.11+0.2%$700,000.00+17,031,530.2%-100.0%$2.21MN/A0.0020Short Interest ↑Positive NewsTIVCTivic Health Systems0.7533 of 5 stars$3.30+0.3%N/A-85.6%$2.02M$957,000.000.0010Earnings ReportShort Interest ↓VEROVenus Concept0.6109 of 5 stars$2.88+8.7%N/A-55.1%$1.90M$67.20M-0.36410Short Interest ↑STSSSharps Technology0.3855 of 5 stars$0.33-2.7%N/AN/A$1.81MN/A-0.043Earnings ReportUpcoming EarningsShort Interest ↑Gap DownAVGRAvingerN/A$0.47flat$5.00+954.9%N/A$1.57M$7.26M-0.0470Analyst ForecastQNRXQuoin Pharmaceuticals1.1185 of 5 stars$0.31+0.2%N/A-67.2%$1.54MN/A-0.084Short Interest ↓ Remove Ads Related Companies and Tools Related Companies Heart Test Laboratories Alternatives Bone Biologics Alternatives T2 Biosystems Alternatives Bluejay Diagnostics Alternatives ENDRA Life Sciences Alternatives Tivic Health Systems Alternatives Venus Concept Alternatives Sharps Technology Alternatives Avinger Alternatives Quoin Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CUTR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cutera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cutera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
